Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 10
Submit an article Journal homepage
97
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients

E Nakou University of Ioannina, Department of Internal Medicine, School of Medicine, 45 110 Ioannina, Greece +30 2651 097 509; +30 2651 097 016; [email protected]
,
TD Filippatos University of Ioannina, Department of Internal Medicine, School of Medicine, 45 110 Ioannina, Greece +30 2651 097 509; +30 2651 097 016; [email protected]
,
EN Liberopoulos University of Ioannina, Department of Internal Medicine, School of Medicine, 45 110 Ioannina, Greece +30 2651 097 509; +30 2651 097 016; [email protected]
,
AD Tselepis University of Ioannina, Laboratory of Biochemistry, Department of Chemistry, 45 110 Ioannina, Greece
,
DN Kiortsis University of Ioannina, Laboratory of Physiology, School of Medicine, 45 110 Ioannina, Greece
,
DP Mikhailidis University College London (UCL), Department of Clinical Biochemistry Royal Free Campus, London, UK
&
MS Elisaf University of Ioannina, Department of Internal Medicine, School of Medicine, 45 110 Ioannina, Greece +30 2651 097 509; +30 2651 097 016; [email protected]
, MD FRSH FASA show all
Pages 1629-1639 | Published online: 21 Jun 2008

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Theodosios D Filippatos & Moses S Elisaf. (2011) Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia. Expert Opinion on Pharmacotherapy 12:12, pages 1945-1958.
Read now
Niki Katsiki, Apostolos I. Hatzitolios & Dimitri P. Mikhailidis. (2011) Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: ‘A new kid on the block’?. Annals of Medicine 43:4, pages 249-258.
Read now
CS Derdemezis, TD Filippatos, AD Tselepis, DP Mikhailidis & MS Elisaf. (2008) Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot study. Expert Opinion on Pharmacotherapy 9:11, pages 1829-1837.
Read now

Articles from other publishers (10)

Bernard Man Yung Cheung, Tommy Tsang Cheung & Nithushi Rajitha Samaranayake. (2013) Safety of antiobesity drugs. Therapeutic Advances in Drug Safety 4:4, pages 171-181.
Crossref
T.D. Filippatos, V. Tsimihodimos, C.S. Derdemezis, I.F. Gazi, V. Saougos, D.P. Mikhailidis, A.D. Tselepis & M.S. Elisaf. (2013) Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile. Nutrition, Metabolism and Cardiovascular Diseases 23:4, pages 330-336.
Crossref
Bernard M.Y. Cheung. (2011) Drug Treatment for Obesity in the Post-Sibutramine Era. Drug Safety 34:8, pages 641-650.
Crossref
TAYFUN EYILETEN, ALPER SONMEZ, MUTLU SAGLAM, ERDINC CAKIR, KAYSER CAGLAR, YUSUF OGUZ, ABDULGAFFAR VURAL, MUJDAT YENICESU & MAHMUT ILKER YILMAZ. (2010) Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy. Nephrology 15:2, pages 225-229.
Crossref
Theodosios D Filippatos. (2010) Combination drug treatment in patients with non-alcoholic fatty liver disease. World Journal of Hepatology 2:4, pages 139.
Crossref
Theodosios D Filippatos. (2010) Combination drug treatment in obese diabetic patients. World Journal of Diabetes 1:1, pages 8.
Crossref
Mingfang Li & Bernard M. Y. Cheung. (2009) Pharmacotherapy for obesity. British Journal of Clinical Pharmacology 68:6, pages 804-810.
Crossref
. (2009) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 16:5, pages 401-405.
Crossref
E. I. Astashkin & M. Glezer. (2009) Cardiac lipotoxic effects of obesity. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 15:3, pages 335-341.
Crossref
Michael I. Koukourakis, Georgia Kambouromiti, Dimitra Pitsiava, Pelagia Tsousou, Maria Tsiarkatsi & George Kartalis. (2009) Serum C-reactive Protein (CRP) Levels in Cancer Patients are Linked with Tumor Burden and are Reduced by Anti-hypertensive Medication. Inflammation 32:3, pages 169-175.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.